Skip To Main Content
 

UNITED STATES RENAL DATA SYSTEM

Home  | About  | Contact

 
Skip Navigation LinksHome > ESRD Quarterly Update - April 2018 - Most Current

Incident and Prevalent counts by quarter
Incident counts of reported ESRD, 2016 Q1 - 2017 Q4
2016^ 2017^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4
0 - 19 286 273 269 263 263 253 266 247
20 - 44 3,751 3,552 3,303 3,458 3,626 3,533 3,200 3,312
45 - 64 12,793 12,003 11,247 11,705 12,665 11,756 11,108 11,437
65 - 74 9,001 8,595 7,971 8,289 8,804 8,567 8,023 8,281
75 + 7,732 7,160 6,671 6,987 7,602 7,289 6,590 7,006
Male 19,572 18,164 16,977 17,830 19,272 18,201 16,973 17,657
Female 13,991 13,419 12,484 12,872 13,688 13,197 12,214 12,626
Diabetes 15,884 14,766 13,730 14,526 15,592 14,541 13,594 14,098
Hypertension 9,321 8,829 8,379 8,742 9,361 9,026 8,437 8,641
Glomerulonephritis 2,525 2,293 2,176 2,211 2,431 2,227 2,000 2,047
Cystic kidney 927 939 867 836 893 872 847 810
Other urologic 451 452 398 426 446 465 395 445
Other cause 3,322 3,289 2,974 3,026 3,105 3,141 2,825 2,806
Unknown cause 146 112 99 102 114 110 89 85
Missing cause 987 903 838 833 1,018 1,016 1,000 1,351
All 33,563 31,583 29,461 30,702 32,960 31,398 29,187 30,283

^ Data as of March 30, 2018
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Point prevalent counts of reported ESRD, 2016 Q1 - 2017 Q4
2016^ 2017^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4
0 - 19 7,654 7,659 7,649 7,591 7,586 7,559 7,530 7,517
20 - 44 106,069 106,272 106,075 106,070 106,289 106,694 106,454 106,336
45 - 64 312,845 315,007 316,376 317,571 319,456 321,124 321,760 322,413
65 - 74 170,327 173,159 175,258 177,387 178,870 181,156 183,472 184,940
75 + 115,856 117,142 118,493 119,326 120,082 121,501 123,034 124,168
Male 412,090 415,885 418,685 421,304 424,116 427,895 430,766 432,812
Female 300,588 303,282 305,094 306,569 308,098 310,070 311,416 312,494
Unknown 73 72 72 72 69 69 68 68
Diabetes 273,640 276,622 278,659 280,411 282,396 284,841 286,498 287,492
Hypertension 182,676 184,540 186,119 187,529 188,808 190,575 192,046 193,091
Glomerulonephritis 113,718 114,164 114,491 114,764 115,118 115,489 115,640 115,822
Cystic kidney 33,942 34,421 34,820 35,203 35,568 35,943 36,338 36,652
Other urologic 11,616 11,743 11,809 11,908 11,975 12,085 12,138 12,223
Other cause 61,859 62,563 62,891 63,223 63,508 64,139 64,494 64,633
Unknown cause 23,589 23,159 22,723 22,256 21,828 21,437 21,081 20,699
Missing cause 11,711 12,027 12,339 12,651 13,082 13,525 14,015 14,762
All 712,751 719,239 723,851 727,945 732,283 738,034 742,250 745,374

^ Data as of March 30, 2018
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Reported Medical Evidence Form data for the incident ESRD population, 2016 Q1 - 2017 Q4
2016^ 2017^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4
White 22,044 20,673 19,387 20,293 21,320 20,630 18,960 19,544
Black/African American 8,475 8,060 7,373 7,664 8,480 7,748 7,376 7,487
Native American/Alaska Native 306 325 289 286 323 290 263 295
Asian 1,418 1,294 1,215 1,289 1,444 1,339 1,254 1,259
Pacific Islander 418 406 395 360 392 392 346 377
Other/Unknown * * * * * * * *
No ME Form 963 883 826 823 1,002 1,000 990 1,314
Hispanic 4,895 4,372 3,998 4,226 4,479 4,370 4,068 4,143
Non-Hispanic 27,766 26,387 24,660 25,665 27,480 26,029 24,131 24,821
Unknown * * * * * * * *
No ME Form 963 883 826 823 1,002 1,000 990 1,314
Hemodialysis (%)1 90.32 89.79 89.17 90.26 90.27 89.24 88.91 89.23
CAPD (%)1 4.66 4.74 5.01 4.41 4.27 4.86 4.9 4.72
CCPD (%)1 5.02 5.45 5.8 5.31 5.45 5.89 6.17 6.04
Other (%)1 0.0062 0.023 0.018 0.024 0.0096 0.0034 0.015 0.011
Unknown (%)1 . . . . . 0.0067 . .
Cathether Only (%)2 62.61 62.21 61.8 63.23 62.99 62.5 63.2 64.85
Catheter w/ maturing AVF (%)2 16.08 16.63 15.84 15.74 15.61 15.58 14.87 14.63
Catheter w/ maturing AVG (%)2 1.6 1.64 1.6 1.6 1.6 1.49 1.39 1.31
AVF (%)2 16.65 16.31 17.2 16.5 16.59 17.1 17.24 15.97
AVG (%)2 2.87 3.08 3.36 2.8 3.05 3.16 3.07 3.05
Other(%)2 0.15 0.085 0.18 0.12 0.13 0.15 0.17 0.11
Unknown(%)2 0.041 0.052 0.02 0.0076 0.032 0.026 0.045 0.087
Pre-ESRD EPO(% Yes)3 19.89 19.9 20.12 20.3 20 21.17 21.17 21.01
Pre-ESRD Nephrology(% Yes)3 74.57 75.53 76.26 75.81 76.38 77.99 78.53 77.23
Mean Serum Albumin(g/dL)4 3.15 3.18 3.21 3.17 3.16 3.21 3.23 3.21
Mean Serum Creatinine(mg/dL)4 6.4 6.37 6.42 6.42 6.41 6.39 6.37 6.42
Mean Hemoglobin(g/dL)4 9.33 9.35 9.38 9.3 9.31 9.35 9.39 9.33
All 33,626 31,644 29,486 30,717 32,962 31,401 29,191 30,284
All with ME Form 32,663 30,761 28,660 29,894 31,960 30,401 28,201 28,970
Dialysis Pts with ME Form 32,102 30,132 28,053 29,291 31,380 29,795 27,583 28,335
Hemodialysis Pts w/ ME Form 28,993 27,055 25,016 26,439 28,327 26,589 24,525 25,284

^ Data as of March 30, 2018.
* Suppressed due to inadequate sample size.
. Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator 'Dialysis Patients with ME Form' counts.
2 Vascular access type percentages shown are based on denominator 'Hemodialysis Patients with ME Form' counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. 'Did patient receive exogenous erythropoetin or equivalent?''
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. 'Was patient under care of nephrologist?''
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator 'All with ME Form' counts.
4 Mean laboratory test values shown are based on denominator 'All with ME Form' counts.
Home   |    Contact Us   |    Search
USRDS Coordinating Center | 1415 Washington Heights, Suite 3645 SPH I | Ann Arbor, MI 48109 | 1-888-99USRDS